This Molina Healthcare Analyst Turns Bearish; Here Are Top 5 Downgrades For Friday
Benzinga·10/24 11:57
Share
Listen to the news
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
Jefferies analyst Michael Sarcone downgraded Inspire Medical Systems, Inc. (NYSE:INSP) from Buy to Hold and cut the price target from $160 to $85. Inspire Medical shares closed at $80.17 on Thursday. See how other analysts view this stock.
Barclays analyst Andrew Mok downgraded Molina Healthcare, Inc. (NYSE:MOH) from Equal-Weight to Underweight and lowered the price target from $185 to $144. Molina Healthcare shares closed at $161.00 on Thursday. See how other analysts view this stock.
HC Wainwright & Co. analyst Andrew S. Fein downgraded Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) from Buy to Neutral and lowered the price target from $60 to $12. Arcturus Therapeutics shares closed at $12.00 on Thursday. See how other analysts view this stock.
Citigroup analyst Joanne Wuensch downgraded Integer Holdings Corporation (NYSE:ITGR) from Buy to Neutral and slashed the price target from $140 to $77. Integer Holdings closed at $73.89 on Thursday. See how other analysts view this stock.
William Blair analyst Dylan Carden downgraded Torrid Holdings Inc. (NYSE:CURV) from Outperform to Market Perform. Torrid Holdings shares closed at $1.47 on Thursday. See how other analysts view this stock.
Considering buying MOH stock? Here’s what analysts think:
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.